Public-domain · open source
OpenJurist
← 164 F.2d 50 - Wesson v. United States

Wesson v. United States’s Empirical Analysis

164 F.2d 50 · 1947

Citation profile

15
cited by 15 later decisions
2
states following
March 1987
most recently cited

13 federal appellate · 2 state decisions

How this case has been cited

Cited by 15 later decisions — most recently March 1987

13 federal appellate · 2 state decisions

4019471950196019701980decided

Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.

Relationships

Relies on Blockburger v. United States · Dunn v. United States · Direct Sales Co. v. United States · Pilgreen v. United States · C. M. Spring Drug Co. v. United States

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 15 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “sufficiently detailed the nature of their practice and the uses they made of the drug to afford the jury a fair opportunity for comparison.”
    1 later decision quote this exact passage · from the majority
  2. “sufficiently representative and unindividualistic so that it will not be likely to mislead.”
    1 later decision quote this exact passage · from the majority

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.